Key Documents

View All Documentation

E6888

Enalapril maleate salt

Name: Enalapril maleate salt
Brand: SIGMA

≥98.0% (HPLC), ACE inhibitor, powder

Synonym(s):

(S)-N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-Ala-Pro maleate salt

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₂₀H₂₈N₂O₅ · C₄H₄O₄

CAS Number:

76095-16-4

Molecular Weight:

492.52

UNSPSC Code:

12352200

PubChem Substance ID:

24894639

NACRES:

NA.77

EC Number:

278-375-7

Assay:

≥98.0% (HPLC)

Form:

powder

Quality level:

100

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Product Name

Enalapril maleate salt, powder, ≥98.0% (HPLC)

Quality Level

100

assay

≥98.0% (HPLC)

form

powder

color

white to off-white

solubility

methanol: ≥50 mg/mL, clear, colorless to yellow

originator

Merck & Co., Inc., Kenilworth, NJ, U.S.

SMILES string

C[C@@H](C(N1[C@H](C(O)=O)CCC1)=O)N[C@H](CC(OCC)=O)CCC2=CC=CC=C2.O=C(OO)/C=C\C(O)=O

InChI

1S/C21H30N2O5.C4H4O5/c1-3-28-19(24)14-17(12-11-16-8-5-4-6-9-16)22-15(2)20(25)23-13-7-10-18(23)21(26)27;5-3(6)1-2-4(7)9-8/h4-6,8-9,15,17-18,22H,3,7,10-14H2,1-2H3,(H,26,27);1-2,8H,(H,5,6)/b;2-1-/t15-,17-,18-;/m0./s1

InChI key

UQKQUZOIQFOJOI-KJHLASMFSA-N

Description

General description

Enalapril is an angiotensin-converting enzyme inhibitor. It is used to treat heart failure and high blood pressure.

Application

Enalapril maleate salt has been used:

to reduce albumin excretion rate (AER) and glomerular lesions
to examine the effects of enalapril pre-treatment on myocardial injury
to investigate its efficacious doses and schedules for mitigation of radiation lung injury

Biochem/physiol Actions

A long-acting angiotensin-converting enzyme inhibitor.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.